BB vs CPRX · P/E 117, rev $549.1M vs P/E 18, rev $491.7M
BlackBerry Ltd (BB) versus Catalyst Pharmaceuticals Inc (CPRX) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
BB currently screens at market cap $6.14B and trailing P/E 116.5. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Not investment advice. Open the BB and CPRX stock pages for the full models.
Not investment advice.